Abstract
To characterise the long-term prognosis of patients with stable coronary artery heart disease by means of 'standard predictors' defined as demographic, clinical and biochemical quantities routinely available in general practices and ascertained at an interview not prompted by renewed cardiac complaints. This is an observational study based on data from 2199 Copenhagen placebo patients from the 'clarithromycin for patients with stable coronary heart disease' trial of patients with stable coronary heart disease. In the trial, we compared the effects of 14 days of clarithromycin treatment versus placebo. The predictors were based on the interview forms and blood samples collected at entry, along with demographic information from hospital files.We studied 'standard predictors' of a composite outcome (myocardial infarction, unstable angina, cerebrovascular disease or all-cause death) and of all-cause death. Using Cox regression, we compared predictions of status at 3, 6 and 9 years without and with the use of 'standard predictors' and used receiver operating characteristic statistic. Few 'standard predictors' were associated (p<0.01) with the composite outcome or with all-cause death. When no 'standard predictors' were included, 63....Continue Reading
References
Feb 13, 2001·The American Journal of Cardiology·A HoffmeisterW Koenig
Sep 28, 2005·International Journal of Cardiology·Takeshi YamamotoTeruo Takano
Dec 13, 2005·BMJ : British Medical Journal·Christian M JespersenUNKNOWN CLARICOR Trial Group
May 3, 2008·Cardiology·Christian GluudUNKNOWN CLARICOR Trial Group
Nov 26, 2010·VASA. Zeitschrift für Gefässkrankheiten·H UthoffB Frauchiger
Nov 27, 2010·Scandinavian Journal of Clinical and Laboratory Investigation·Marina J HarutyunyanUNKNOWN CLARICOR Trial Group
Dec 16, 2010·Biometrics·R M Pfeiffer, M H Gail
Feb 24, 2011·JAMA : the Journal of the American Medical Association·Issa J Dahabreh, David M Kent
Mar 31, 2011·Cardiology·Per WinkelUNKNOWN CLARICOR Trial Group
Aug 4, 2011·Scandinavian Journal of Public Health·Karin Helweg-Larsen
Aug 4, 2011·Scandinavian Journal of Public Health·Elsebeth LyngeMatejka Rebolj
Jan 20, 2012·Journal of Clinical Epidemiology·Erik KjollerUNKNOWN CLARICOR Trial Group
Jan 27, 2012·BMJ : British Medical Journal·Morten SchmidtHenrik Toft Sørensen
Jul 6, 2012·The New England Journal of Medicine·Lesley A InkerUNKNOWN CKD-EPI Investigators
Dec 22, 2012·Journal of Clinical Epidemiology·Luc J M SmitsSimone J S Sep
Sep 3, 2013·European Heart Journal·UNKNOWN Task Force MembersJose Luis Zamorano
Jul 16, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Mette BjerreUNKNOWN Claricor Trial Group
Jul 30, 2014·American Heart Journal·Erik KjøllerUNKNOWN CLARICOR Trial Group
Aug 12, 2014·JAMA Internal Medicine·Philippe Gabriel StegUNKNOWN Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators
Jan 21, 2015·International Journal of Cardiology·Per WinkelUNKNOWN CLARICOR trial group
Jun 30, 2015·Journal of Clinical Epidemiology·William CampbellA Cecile J W Janssens
Feb 27, 2016·Circulation. Heart Failure·Scott D SolomonJohn J V McMurray
Sep 14, 2016·Maturitas·Johanna Helmersson-KarlqvistAnders Larsson
Aug 5, 2017·European Heart Journal. Acute Cardiovascular Care·Stuart J PocockHéctor Bueno
Mar 29, 2017·Diagnostic and Prognostic Research·Per WinkelChristian Gluud
Citations
Mar 3, 2020·Journal of the American Heart Association·Jakob SchroderJens Kastrup
Apr 17, 2020·European Journal of Heart Failure·Zofia ParmaP Gabriel Steg
Aug 21, 2020·BMJ Open·Per WinkelChristian Gluud
Dec 15, 2020·Journal of Interventional Cardiology·Shigetaka KageyamaYuichiro Maekawa
Apr 15, 2020·Atherosclerosis·Mette BjerreChristian Gluud
Aug 13, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Per WinkelChristian Gluud